[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339322-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339322-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pten-and-p-4e-bp1-might-be-associated-with-postoperative-recurrence-of-rectal-cancer-patients-undergoing-concurrent-radiochemotherapy-research-open-access","PTEN and P-4E-BP1 might be associated with postoperative recurrence of rectal cancer patients undergoing concurrent radiochemotherapy - Research Open Access","","Local recurrence after surgery and radiochemotherapy seriously worsens prognosis for locally advanced rectal cancer (LARC) patients, motivating identification of molecular markers that predict radiochemotherapy sensitivity and postoperative outcomes. This study evaluated clinicopathological factors and immunohistochemical expression of PTEN, SIRT1, p-4E-BP1, and pS6 in 73 LARC patients with local recurrence and 76 without. PTEN was higher and p-4E-BP1 lower in non-recurrence cases, and TNM stage, LVI, PTEN, and p-4E-BP1 independently predicted recurrence.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pten-and-p-4e-bp1-might-be-associated-with-postoperative-recurrence-of-rectal-cancer-patients-undergoing-concurrent-radiochemotherapy-research-open-access/339322/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pten-and-p-4e-bp1-might-be-associated-with-postoperative-recurrence-of-rectal-cancer-patients-undergoing-concurrent-radiochemotherapy-research-open-access/339322.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study aim regarding PTEN and p-4E-BP1?","Question",{"text":63,"@type":64},"To identify potential tumor biomarkers for predicting postoperative recurrence in LARC patients undergoing surgery with concurrent radiochemotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients grouped in the study?",{"text":68,"@type":64},"Patients with local recurrence (73 cases) were compared with patients without local recurrence (76 cases) based on clinicopathological data and immunohistochemical protein expression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which markers and clinical factors were linked to local recurrence risk?",{"text":72,"@type":64},"TNM stage, lymphatic vessel invasion (LVI), PTEN, and p-4E-BP1 were reported as independent risk factors for local recurrence after LARC surgery combined with concurrent radiochemotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339322,1790474964,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Zhang et al. BMC Cancer (2024) 24:582 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12339-x](https://doi.org/10.1186/s12885-024-12339-x)  \nRESEARCH Open Access  \nPTEN and P-4E-BP1 might be associated with postoperative recurrence of rectal cancer patients undergoing concurrent radiochemotherapy  \nHeng Zhang 1, Xiaofan Li2, Wanjun Sun 1, Haoren Qin 1, Haipeng Li 1, Hao Yan 1, Huaqing Wang 1, Xipeng Zhang3, Shiwu Zhang4 and Hui Wang 1*  \nAbstract  \nBackground Local recurrence after surgery and radiochemotherapy seriously affects the prognosis of locally advanced rectal cancer (LARC) patients. Studies on molecular markers related to the radiochemotherapy sensitivity of cancers have been widely carried out, which might provide valued information for clinicians to carry out individual treatment.  \nAim To find potential biomarkers of tumors for predicting postoperative recurrence.  \nMethods In this study, LARC patients undergoing surgery and concurrent radiochemotherapy were enrolled. We focused on clinicopathological factors and PTEN, SIRT1, p-4E-BP1, and pS6 protein expression assessed by immunohistochemistry in 73 rectal cancer patients with local recurrence and 76 patients without local recurrence. Results The expression of PTEN was higher, while the expression of p-4E-BP1 was lower in patients without local recurrence than in patients with local recurrence. Moreover, TNM stage, lymphatic vessel invasion (LVI), PTEN and p-4E-BP1 might be independent risk factors for local recurrence after LARC surgery combined with concurrent radiochemotherapy.  \nConclusions This study suggests that PTEN and p-4E-BP1 might be potential biomarkers for prognostic prediction and therapeutic targets for LARC.  \nKeywords Rectal cancer, Concurrent radiochemotherapy, Local recurrence, PTEN, 4E-BP1  \n*Correspondence:  \nHui Wang  \n[ezxwanghui@sina.com](ezxwanghui@sina.com)  \n1Department of Oncology, Tianjin Union Medical Center, Nankai University, No. 190 Jieyuan Road, Hongqiao District, Tianjin  \n300121, P. R. China  \n2Department of Oncology, People’s Hospital of Rongcheng, ShandongRongcheng, P. R. China  \n3Department of Colorectal Surgery, Tianjin Union Medical Center, Nankai University, Tianjin, P. R. China  \n4Department of Pathology, Tianjin Union Medical Center, Nankai University, Tianjin, P. R. China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nZhang et al. BMC Cancer (2024) 24:582  \nBackground  \nIn recent years, the incidence of colorectal cancer (CRC) in China has been increasing continuously, and it has become the fifth most fatal malignant tumor [1]. Asa number of studies have confirmed that concurrent radiochemotherapy can reduce local recurrence after rectal cancer surgery, adjuvant/neoadjuvant radiochemotherapy has become a standard treatment for stage II/III rectal cancer in China [2–4]. However, the rate of local recurrence in the","cbCairNTOBo55SMn","https://ap.wps.com/l/cbCairNTOBo55SMn","pdf",1645992,"English","# Background\n# Aim\n# Methods\n## Patients\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What was the study aim regarding PTEN and p-4E-BP1?\",\"answer\":\"To identify potential tumor biomarkers for predicting postoperative recurrence in LARC patients undergoing surgery with concurrent radiochemotherapy.\"},{\"question\":\"How were patients grouped in the study?\",\"answer\":\"Patients with local recurrence (73 cases) were compared with patients without local recurrence (76 cases) based on clinicopathological data and immunohistochemical protein expression.\"},{\"question\":\"Which markers and clinical factors were linked to local recurrence risk?\",\"answer\":\"TNM stage, lymphatic vessel invasion (LVI), PTEN, and p-4E-BP1 were reported as independent risk factors for local recurrence after LARC surgery combined with concurrent radiochemotherapy.\"}]","PTEN and P-4E-BP1 might be associated with postoperative recurrence of rectal cancer patients undergoing concurrent radiochemotherapy - Research Open Access | PDF",1790029534,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f215288a7ab931ff0fc65164254f091.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4cf3db4020abcdf7f107a60008c70bf.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/effec990cfe6f404e6b4211123b2fea7.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c12f95f11f55b362233bed54cd7bbfe3.webp",980,1306]